Regeneron (NASDAQ: REGN) reported Q1 EPS of $11.49, $1.45 better than the analyst estimate of $10.04. Revenue for the quarter came in at $2.97 billion versus the consensus estimate of $2.73 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.